{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Amie", "organization": "", "rank": 1, "lastname": "TSANG"}], "original": "By AMIE TSANG"}, "news_desk": "Business", "slideshow_credits": null, "abstract": null, "multimedia": [{"type": "image", "url": "images/2016/08/24/business/24db-newsletter/24db-newsletter-thumbWide.jpg", "legacy": {"wide": "images/2016/08/24/business/24db-newsletter/24db-newsletter-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/08/24/business/24db-newsletter/24db-newsletter-articleLarge.jpg", "legacy": {"xlarge": "images/2016/08/24/business/24db-newsletter/24db-newsletter-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "width": 600, "subtype": "xlarge", "height": 400}, {"type": "image", "url": "images/2016/08/24/business/24db-newsletter/24db-newsletter-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/08/24/business/24db-newsletter/24db-newsletter-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"main": "Morning Agenda: Fining Apollo, When Deals Go Sour, and Controversy at Turing"}, "print_page": null, "keywords": [{"value": "Private Equity", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Ethics and Official Misconduct", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Shkreli, Martin (1983- )", "is_major": "N", "rank": "5", "name": "persons"}, {"value": "Apollo Global Management", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "LyondellBasell", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Securities and Exchange Commission", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "Turing Pharmaceuticals AG", "is_major": "N", "rank": "9", "name": "organizations"}], "snippet": "A private equity firm is fined for misleading investors, a once-promising relationship goes sour, and a controversial pharmaceuticals company is back in the headlines....", "source": "The New York Times", "lead_paragraph": "A private equity firm is fined for misleading investors, a once-promising relationship goes sour, and a controversial pharmaceuticals company is back in the headlines.", "word_count": "541", "pub_date": "2016-08-24T04:00:00+0000", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/08/24/business/dealbook/apollo-sec-turing-lawsuit-shkreli.html", "_id": "57bd70d595d0e021d79824af"}